'Dumping' war may kill drug industry

A cash reward plan in the pharmaceutical market has produced negative side effects that require the attention of policymakers, including the possibility of predatory pricing, commonly referred to as “dumping.”

A market insider said the hospital bidders’ overheated competition and demand for lower drug prices in large hospitals are becoming a huge headache for pharmaceutical companies and wh...